Karolinska Development has named Per Aniansson has its chief financial officer and investment director to replace Fredrik Järrsten.

Per Aniansson, general partner at venture capital firm RSQ Capital, has been named chief financial officer (CFO) and investment director of Karolinska Development, the commercialisation firm set up by Karolinska Institute.

He will take up the position on March 7 and will initially work on a part-time basis. He replaces Fredrik Järrsten, who announced his intention to step down from his positions as CFO and deputy CEO in September 2020 to join an undisclosed life sciences company.

Aniansson’s career has included stints on several boards of directors, including as chairman, and at Karolinska Development portfolio companies such as regenerative implant producer OssDsign.

He has also served as CEO of two medtech developers and CFO of a wind power company.

Viktor Drvota, chief executive of Karolinska Development, said: “I am extremely pleased to welcome Per Aniansson as our new CFO and investment director.

“His extensive experience in investments and business development in the life science industry will be of great value during Karolinska Development’s continued journey.

“At the same time, I would like to extend my appreciation to Fredrik Järrsten for his significant efforts and great commitment during the time in the company’s management team and wish him all the best for the future.”

Aniansson’s appointment follows the promotion of general counsel Johan Dighed to deputy chief executive last week, completing the leadership transition following Järrsten’s departure.

– Image courtesy of LinkedIn